USFDA Guidance for Data Integrity | USFDA Guidelines for Pharmaceutical | Easy Explanation

Поділитися
Вставка
  • Опубліковано 22 вер 2021
  • 'Data Integrity & Compliance with Drug CMGP' Question and Answers Guidance for Industry released in Dec 2018.
    Explains the details about USFDA expectation on data integrity and ALCOA principles.
    Give details about controls on electronic records, metadata, audit trail, static & dynamic data, data backup, data invalidation, computer system validation, shared logins, control of blank forms/ formats, audit trail review, audit trail frequency, electronic signatures, system suitability, reprocessing of chromatograms, training on data integrity, handling of data integrity problems.
    Other Useful Presentations:
    1. USFDA Guidance on Pharmaceutical Quality System • USFDA Guidance for Pha...
    2. ICH Q10 Guidance on Quality Systems • ICH Q10 Guidance for P...
    3. Interview Question 'Tell Me about yourself' • How to introduce youse...
    4. 5 Step formula for interview preparation: • How to prepare for int...
    5. Interview Dont's, things you should not talk in interview: • Don'ts of Interview | ...
    About the channel:
    The channel has been developed with view of sharing information on Pharmaceutical Guidelines & Guidance..
    Kindly subscribe to channel at: / @proftalks1680

КОМЕНТАРІ • 8